Skip to content skip to primary navi skip to secondary navi skip to meta navi search

Active Trials

HD16

Patient attributes

Stage CS (PS)

  • IA (except for LPHD), IB, IIA, IIB without one of the following risk factors:
  • Large mediastinal mass (? one third of the maximum transverse thorax diameter); extranodal involvement; high ESR (? 50 mm/h in case of present A symptoms, ? 30 mm/h in case of present B symptoms); 3 or more involved lymph node areas

Age

  • 18-75

Read more …

HD18

Patient attributes

Stage

  • IIB (with large mediastinal mass and/or extranodal involvement as risk factors), III A/B and IV A/B

Age

  • 18-60

Read more …

HD-R3i

Studiendesign

  • Phase I/II, multizentrisch, randomisiert (nur Phase II)

Patientenmerkmale

Alter

  • 18-60 Jahre

Read more …